New Delhi [India], October 27 (ANI): The Supreme Court on Tuesday questioned the Centre over the massive disparity between the maximum retail price (MRP) of medicines and their price to retailers, asking why the system appeared to favour pharmaceutical manufacturers over patients. A bench of Justices Vikram Nath and Sandeep Mehta criticised the government's reluctance to regulate medicine prices more extensively,
This is a summary. For the full story, refer to the original source. Public of India presents verified citizen-relevant reporting.